Di Nicolantonio F, Vitiello PP, Marsoni S, Siena S, Tabernero J, Trusolino L, et al. Precision oncology in metastatic colorectal cancer — from biology to medicine. Vol. 18, Nature Reviews Clinical Oncology. Nature Research; 2021. p. 506–25.

Keller L, Belloum Y, Wikman H, Pantel K. Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond. Vol. 124, British Journal of Cancer. Springer Nature; 2021. p. 345–58.

Stejskal P, Goodarzi H, Srovnal J, Hajdúch M, van ’t Veer LJ, Magbanua MJM. Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance. Vol. 22, Molecular Cancer. BioMed Central Ltd; 2023.

Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016Sep 1;35(3):347–76.

Article  PubMed  PubMed Central  CAS  Google Scholar 

P. Mandel PM. Nuclear Acids In Human Blood Plasma. C R Seances Soc Biol Fil. 1948;

Leon SA, Shapiro B, Sklaroff DM YM. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;

Schwarzenbach H, Stoehlmacher J, Pantel K GE. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann N Y Acad Sci. 2008;

Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Vol. 20, Nature Reviews Genetics. Nature Publishing Group; 2019. p. 71–88.

Alix-Panabières C, Pantel K. Clinical applications of circulating tumor cells and circulating tumor DNA as liquid biopsy. Vol. 6, Cancer Discovery. American Association for Cancer Research Inc.; 2016. p. 479–91.

Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224).

D. Schrag. A prospective study of a multi-cancer early detection blood test. Abstract 903O. https://doi.org/10.1016/j.annonc.2022.07.1029.

Park BH, Shen SY, Min J, Fleshner N, Knox J, May T, et al. Abstract 1030: Development of a genome-wide methylome enrichment platform for multi-cancer early detection (MCED). Cancer Res. 2023 May 29;83(7_Supplement):1030–1030.

Lone SN, Nisar S, Masoodi T, Singh M, Rizwan A, Hashem S, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Vol. 21, Molecular Cancer. BioMed Central Ltd; 2022.

Barault L, Amatu A, Siravegna G, Ponzetti A, Moran S, Cassingena A, et al. Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer. Gut. 2018Nov 1;67(11):1995–2005.

Article  PubMed  CAS  Google Scholar 

Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D, et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol. 2021Sep 1;32(9):1167–77.

Article  PubMed  CAS  Google Scholar 

Lennon AM, Buchanan AH, Kinde I, Warren A, Honushefsky A, Cohain AT, et al. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science. 2020Jul 3. https://doi.org/10.1126/science.abb9601.

Article  PubMed  PubMed Central  Google Scholar 

Tie J, Cohen JD, Wang Y, Christie M, Simons K, Lee M, et al. Circulating tumor dna analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer. JAMA Oncol. 2019Dec 1;5(12):1710–7.

Article  PubMed  PubMed Central  Google Scholar 

Cheng C, Omura-Minamisawa M, Kang Y, Hara T, Koike I, Inoue T. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy. Cancer Sci. 2009;100(2):303–9.

Article  PubMed  CAS  Google Scholar 

Schütz E, Akbari MR, Beck J, Urnovitz H, Zhang WW, Bornemann-Kolatzki K, et al. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clin Chem. 2015Jan 1;61(1):239–48.

Article  PubMed  Google Scholar 

Urosevic N, Merritt AJ, Inglis TJJ. Plasma cfDNA predictors of established bacteraemic infection. Access Microbiol. 2022 Jun 14;4(6).

Grabuschnig S, Bronkhorst AJ, Holdenrieder S, Rodriguez IR, Schliep KP, Schwendenwein D, et al. Putative origins of cell-free DNA in humans: A review of active and passive nucleic acid release mechanisms. Vol. 21, International Journal of Molecular Sciences. MDPI AG; 2020. p. 1–24.

Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, et al. Liquid biopsies come of age: Towards implementation of circulating tumour DNA. Vol. 17, Nature Reviews Cancer. Nature Publishing Group; 2017. p. 223–38.

An Y, Zhao X, Zhang Z, Xia Z, Yang M, Ma L, et al. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation. Nat Commun. 2023;14(1).

Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019Jun 20;570(7761):385–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rostami A, Lambie M, Yu CW, Stambolic V, Waldron JN, Bratman S V. Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics. Cell Rep. 2020 Jun 30;31(13).

Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012Dec;45(6):487–98.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Vol. 32, Trends in Biochemical Sciences. 2007. p. 37–43.

Aucamp J, Bronkhorst AJ, Badenhorst CPS, Pretorius PJ. The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. Biol Rev. 2018Aug 1;93(3):1649–83.

Article  PubMed  Google Scholar 

Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D, et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature. 2012;486(7404):532–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Siravegna G, Mussolin B, Buscarino M, Corti G, Cassingena A, Crisafulli G, et al. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat Med. 2015;21(7):795–801.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science (80- ). 2018 Feb 23;359(6378):926–30.

van der Meer AJ, Kroeze A, Hoogendijk AJ, Soussan AA, van der Schoot CE, Wuillemin WA, et al. Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans. Blood Adv. 2019Mar 12;3(5):724–8.

Article  PubMed  PubMed Central  Google Scholar 

Davidson BA, Miranda AX, Croessmann S, Park BH. Abstract 13: Novel CRISPR screening approach identifies regulators of cell-free DNA release in vitro. Cancer Res. 2022 Jun 15;82(12_Supplement):13–13.

Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Vol. 50, Histopathology. 2007. p. 113–30.

Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, et al. Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterology. 2015Jan 1;148(1):77-87.e2.

Article  PubMed  CAS  Google Scholar 

Medico E, Russo M, Picco G, Cancelliere C, Valtorta E, Corti G, et al. The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets. Nat Commun. 2015Apr;30:6.

Google Scholar 

Durinikova E, Reilly NM, Buzo K, Mariella E, Chilà R, Lorenzato A, et al. Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer. Clin Cancer Res. 2022Sep 1;28(17):3874–89.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arena S, Corti G, Durinikova E, Montone M, Reilly NM, Russo M, et al. A subset of colorectal cancers with cross-sensitivity to olaparib and oxaliplatin. Clin Cancer Res. 2020Mar 15;26(6):1372–84.

Article  PubMed  CAS  Google Scholar 

Lazzari L, Corti G, Picco G, Isella C, Montone M, Arcela P, et al. Patient-derived xenografts and matched cell lines identify pharmacogenomic vulnerabilities in colorectal cancer. Clin Cancer Res. 2019Oct 15;25(20):6243–59.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Corti G, Bartolini A, Crisafulli G, Novara L, Rospo G, Montone M, et al. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology. Clin Colorectal Cancer. 2019Jun 1;18(2):91-101.e3.

Article  PubMed  Google Scholar 

Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, et al. Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell. 2018Apr 9;33(4):676-689.e3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Eide PW, Bruun J, Lothe RA, Sveen A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci Rep. 2017Nov 30;7(1):16618.

Article  PubMed  PubMed Central  Google Scholar 

Isella C, Brundu F, Bellomo SE, Galimi F, Zanella E, Porporato R, et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer. Nat Commun. 2017May 31;8(1):15107.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: A flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014May 15;30(10):1363–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pidsley R, Zotenko E, Peters TJ, Lawrence MG, Risbridger GP, Molloy P, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016 Oct 7;17(1).

Price ME, Cotton AM, Lam LL, Farré P, Emberly E, Brown CJ, et al. Additional annotation enhances potential for biologically-relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip array. Epigenetics and Chromatin. 2013;6(1).

Triche TJ Jr, Weisenberger DJ, Van Den Berg D, Laird PW, Siegmund KD. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res. 2013;41(7): e90.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417–25.

Article  PubMed  PubMed Central  CAS